Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - BMS
gabapentin - Generic mfg.
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42707468
 
Caijiu Deng; Haoran Su; Hehong Bao; Hejing Bao; Jiazhu Hu; Liping Lin; Wanmin Huan; Xi Luo; Xiaolong Cao; Xiaosong Wu
 
Sep 9, 2026
 
Prev Next